 Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators.  Manual de Medicina de Familia - Página 126de Mark A. Graber, Matthew L. Lanternier - 2002 - 968 páginasVista previa restringida - Acerca de este libro
 | M. Gabriel Khan - 2006 - 548 páginas
...Engl I Med 1993:329:673. HOPE: The Heart Outcomes Prevention Evaluation Study Investigators: Effect of an angiotensin-converting-enzyme inhibitor, ramipril,...cardiovascular events in high-risk patients. N Engl I Med 2000:342:145-153. Khan M Gabriel: Acute myocardial infarction. In Heart Disease Diagnosis and... | |
 | Brian P. Griffin, Curtis M. Rimmerman, Eric J. Topol - 2006 - 830 páginas
...Am I Med 2003; 114:445453. 46. The Heart Outcomes Prevention Evaluation Study Investigators. Effect of an angiotensin-converting-enzyme inhibitor, ramipril,...cardiovascular events in high-risk patients. N Engl I Med 2000; 342:145-153. 47. Fox KM. Efficacy on perindopril in reduction of cardiovascular events... | |
 | Anthony J. Zollo - 2005 - 688 páginas
...Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981 -2997, 2002. Yusuf S, Sleight P, Pogue J, et al: Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study lnvestigators. N Engl J Med 342:145-153, 2000. Staessen... | |
 | Ian McConachie - 2006 - 456 páginas
...patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000; 355:1575-81. 7. Yusuf S. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New Engl J Med 2000; 342(3): 145-53.... | |
 | Harold V. Panglossi - 2006 - 204 páginas
...miocardico. Lancet 1999 354, 447-55. [100] Yusuf S; Sleight P; Pogue J; Bosch J; Davies R; Dagenais G. Effects of an angiotensinconverting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 342, 145-53. [101]... | |
 | Joint Specialty Committee on Renal Medicine (Great Britain) - 2006 - 103 páginas
...disease. Miner Electrolyte Metab 1998;24:296— 301. 372. Yusuf S, Sleight P, Pogue J, Bosch J, et al, Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53. 373. Effects... | |
 | Uwe Lendeckel, Nigel M. Hooper - 2006 - 374 páginas
...G, 2000, The Heart Outcomes Prevention Evaluation Study: effects of an angiotensin-converting enzyme inhibitor ramipril on cardiovascular events in high-risk patients. N Engl J Med. 342: 145-153. Chapter 7 Hepatitis C Viral Proteases And Inhibitors Mingjun Huang, Avinash Phadke and... | |
 | Christos S. Mantzoros - 2007 - 553 páginas
...risk. Hypertension 2004;43:941, 942. 144. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-convertingenzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342: 145-153. 145.... | |
 | Harold P. Adams, Gregory J. Del Zoppo, Rudiger Von Kummer - 2006 - 353 páginas
...PROGRESS Trial. Stroke. 2004;35:116-121. 44. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N EnglJ Med. 2QQQ;342: 145-153. 45. PROGRESS... | |
 | Martial G. Bourassa, Jean-Claude Tardif (M.D.) - 2006 - 520 páginas
...failure. Am J Clin Nutr 2001;73:21924. 83. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensinconverting-enzyme inhibitor,...ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342: 145-53. 84. Griendling... | |
| |
